CLINICAL_TRIALS
trial_result
· 2017-05-15
Clinical Trial Update: A Study of MLN0264 in Patients With Pancreatic Cancer [Phase 2]
Summary
Phase 2 study of MLN0264 in pancreatic adenocarcinoma was terminated, with results posted in May 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-05-15